Onsdag 3 Juni | 10:13:59 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-10-29 08:00 Kvartalsrapport 2026-Q3
2026-08-06 08:00 Kvartalsrapport 2026-Q2
2026-04-28 - Kvartalsrapport 2026-Q1
2026-02-11 - Bokslutskommuniké 2025
2025-10-30 - Kvartalsrapport 2025-Q3
2025-08-07 - Kvartalsrapport 2025-Q2
2025-04-29 - Kvartalsrapport 2025-Q1
2025-04-11 - X-dag ordinarie utdelning REG1V 0.40 EUR
2025-04-10 - Årsstämma
2025-02-13 - Bokslutskommuniké 2024
2024-10-31 - Kvartalsrapport 2024-Q3
2024-08-08 - Kvartalsrapport 2024-Q2
2024-04-25 - Kvartalsrapport 2024-Q1
2024-04-05 - X-dag ordinarie utdelning REG1V 0.38 EUR
2024-04-04 - Årsstämma
2024-02-15 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-08-10 - Kvartalsrapport 2023-Q2
2023-04-27 - Kvartalsrapport 2023-Q1
2023-03-24 - X-dag ordinarie utdelning REG1V 0.36 EUR
2023-03-23 - Årsstämma
2023-02-09 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-08-04 - Kvartalsrapport 2022-Q2
2022-04-28 - Kvartalsrapport 2022-Q1
2022-04-11 - X-dag ordinarie utdelning REG1V 0.34 EUR
2022-04-08 - Årsstämma
2022-02-10 - Bokslutskommuniké 2021
2021-10-21 - Kvartalsrapport 2021-Q3
2021-08-05 - Kvartalsrapport 2021-Q2
2021-04-23 - Kvartalsrapport 2021-Q1
2021-03-18 - X-dag ordinarie utdelning REG1V 0.32 EUR
2021-03-17 - Årsstämma
2021-02-11 - Bokslutskommuniké 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-08-06 - Kvartalsrapport 2020-Q2
2020-06-09 - X-dag ordinarie utdelning REG1V 0.30 EUR
2020-06-08 - Årsstämma
2020-04-22 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-10-24 - Kvartalsrapport 2019-Q3
2019-08-15 - Kvartalsrapport 2019-Q2
2019-04-16 - Kvartalsrapport 2019-Q1
2019-03-21 - X-dag ordinarie utdelning REG1V 0.28 EUR
2019-03-20 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-10-25 - Kvartalsrapport 2018-Q3
2018-08-06 - Kvartalsrapport 2018-Q2
2018-04-20 - Kvartalsrapport 2018-Q1
2018-03-21 - X-dag ordinarie utdelning REG1V 0.78 EUR
2018-03-20 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-10-26 - Kvartalsrapport 2017-Q3
2017-08-07 - Kvartalsrapport 2017-Q2
2017-05-22 - Årsstämma
2017-04-20 - Kvartalsrapport 2017-Q1
2017-03-23 - X-dag ordinarie utdelning REG1V 0.74 EUR
2017-02-16 - Bokslutskommuniké 2016
2016-10-31 - Kvartalsrapport 2016-Q3
2016-08-08 - Kvartalsrapport 2016-Q2
2016-04-25 - Kvartalsrapport 2016-Q1
2016-03-16 - X-dag ordinarie utdelning REG1V 0.70 EUR
2016-03-15 - Årsstämma
2016-02-15 - Bokslutskommuniké 2015
2015-10-27 - Kvartalsrapport 2015-Q3
2015-08-10 - Kvartalsrapport 2015-Q2
2015-04-24 - Kvartalsrapport 2015-Q1
2015-03-20 - X-dag ordinarie utdelning REG1V 0.45 EUR
2015-03-19 - Årsstämma
2015-02-12 - Bokslutskommuniké 2014
2014-10-21 - Kvartalsrapport 2014-Q3
2014-08-04 - Kvartalsrapport 2014-Q2
2014-04-24 - Kvartalsrapport 2014-Q1
2014-03-21 - X-dag ordinarie utdelning REG1V 0.30 EUR
2014-03-20 - Årsstämma
2014-02-12 - Bokslutskommuniké 2013
2013-12-11 - X-dag bonusutdelning REG1V 0.3
2013-12-09 - Extra Bolagsstämma 2013
2013-10-22 - Kvartalsrapport 2013-Q3
2013-08-28 - Kapitalmarknadsdag 2013
2013-08-05 - Kvartalsrapport 2013-Q2
2013-08-02 - X-dag bonusutdelning REG1V 0.12
2013-04-19 - Kvartalsrapport 2013-Q1
2013-03-28 - Split REG1V 10:1
2013-03-22 - X-dag ordinarie utdelning REG1V 0.02 EUR
2013-03-21 - Årsstämma
2013-02-08 - Bokslutskommuniké 2012
2012-10-19 - Kvartalsrapport 2012-Q3
2012-08-06 - Kvartalsrapport 2012-Q2
2012-04-19 - Kvartalsrapport 2012-Q1
2012-03-29 - X-dag ordinarie utdelning REG1V 0.02 EUR
2012-03-28 - Årsstämma
2012-02-16 - Bokslutskommuniké 2011
2011-10-26 - Kvartalsrapport 2011-Q3
2011-08-08 - Kvartalsrapport 2011-Q2
2011-04-27 - Kvartalsrapport 2011-Q1
2011-04-01 - X-dag ordinarie utdelning REG1V 0.02 EUR
2011-03-31 - Årsstämma
2011-02-16 - Bokslutskommuniké 2010
2010-04-09 - X-dag ordinarie utdelning REG1V 0.01 EUR
2009-04-16 - X-dag ordinarie utdelning REG1V 0.02 EUR
2008-04-03 - X-dag ordinarie utdelning REG1V 0.04 EUR
2007-04-09 - X-dag ordinarie utdelning REG1V 0.01 EUR
2006-03-31 - X-dag ordinarie utdelning REG1V 0.00 EUR
2005-04-01 - X-dag ordinarie utdelning REG1V 0.00 EUR
2004-03-29 - X-dag ordinarie utdelning REG1V 0.00 EUR
2003-03-24 - X-dag ordinarie utdelning REG1V 0.00 EUR
2002-04-15 - X-dag ordinarie utdelning REG1V 0.00 EUR

Beskrivning

LandFinland
ListaMid Cap Helsinki
SektorHälsovård
IndustriMedicinteknik
Revenio är en global leverantör av omfattande diagnostiska lösningar för ögonvård. Gruppen erbjuder verktyg för att diagnostisera glaukom, diabetisk retinopati och makuladegeneration (AMD). Revenios oftalmiska diagnostiska lösningar inkluderar mätenheter för intraokulärt tryck (IOP) (tonometrar), ögonbottenavbildningsenheter och perimetrar samt mjukvarulösningar under varumärket iCare.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-28 12:34:00

Revenio Group Corporation | Stock Exchange Release | May 28, 2026 at 13:34:00 EEST

Revenio Group Corporation (“Revenio”) announced today that it has completed the acquisition of the entire share capital of LT International SAS, the parent company of the Visionix International group (“Visionix”). The signing of the transaction was announced on April 13, 2026.

Following the closing of the transaction, Revenio strengthens its Leadership Team to support the integration and development of the joint organization. The following persons have today been appointed to Revenio’s Leadership Team:

  • Mari Korhonen, Vice President, Strategy & Business Development – at Revenio since May 2022
  • Jussi Nevanlinna, Vice President, Marketing – at Revenio since February 2026
  • Haniel Abitbol, Vice President, R&D – at Visionix since 2012
  • Umberto Bargiggia, Vice President, International Sales – at Visionix since 2021

Introductions of the new Leadership Team members will be available later today at https://www.reveniogroup.fi/en/investors/corporate_governance/leadership_team.

Marco Rizzardo, Vice President, R&D, will leave his position in the Leadership Team as part of the changes. In addition, the title of John Floyd changes to Vice President, U.S. Sales, and the title of Erkki Tala to Vice President, Products.

“First of all, I want to warmly welcome all Visionix employees to Revenio Group. Combining the knowledge and expertise of both iCare and Visionix positions us well for the journey ahead. I truly believe we have a unique opportunity not only to build a stronger company together, but also to share future successes together as one team. Our strengthened Leadership Team brings together deep expertise from both Revenio and Visionix and will play a key role in supporting the integration, driving change, and building our future together. I am excited about what we can achieve as one organization”, comments Jouni Toijala, CEO of Revenio.

As of today, Revenio’s Leadership team consists of the following persons:

  • Jouni Toijala, Chief Executive Officer
  • Juha Jaatinen, Interim Chief Financial Officer
  • Heli Huopaniemi, Vice President, Quality
  • John Floyd, Vice President, U.S. Sales
  • Hanna Vuornos, Vice President, People & Culture
  • Ari Isomäki, Vice President, Operations
  • Erkki Tala, Vice President, Products
  • Mari Korhonen, Vice President, Strategy & Business Development
  • Jussi Nevanlinna, Vice President, Marketing
  • Haniel Abitbol, Vice President, R&D
  • Umberto Bargiggia, Vice President, International Sales

As announced on May 13, 2026, Revenio has appointed Jukka Kainulainen as the new permanent Chief Financial Officer and member of the Leadership Team. Kainulainen will assume the position no later than September 1, 2026. Juha Jaatinen will continue as interim CFO until then and will support Kainulainen throughout the onboarding period.

For further information, please contact
CEO Jouni Toijala
+358 50 484 0085
jouni.toijala@revenio.fi

Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Principal media
www.reveniogroup.fi/en

Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix.

In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.